Systemic sclerosis & Raynaud's

Epidemiology and Survival of Systemic Sclerosis–Sarcoidosis Overlap Syndrome

J RheumatolPublished Retrospective cohort study

Authors' conclusion

Sarcoidosis in SSc is rare but appears to occur more frequently than in the general population. It is associated with pulmonary, lymph node, cutaneous, joint, and hepatic involvement. Stroke occurs more frequently in patients with SSc-sarcoidosis but with no differences in survival.

Study context

Population
Patients fulfilling the ACR/EULAR classification criteria for systemic sclerosis (SSc), with and without sarcoidosis
Participants
1,977 patients
Exposure
SSc with sarcoidosis vs SSc without sarcoidosis
  • SSc-sarcoidosisn = 6
  • SScn = 1,971reference
Outcome
Time from diagnosis to all-cause mortality
Methodological detailsKaplan-Meier survival analysis
  • Kaplan-Meier survival analysis

Main finding

As reported in the abstract

Median survival

P = 0.55

Observational data: associations, not effects.

Further findings

Age at SSc onset

ILD

Pulmonary hypertension

Abnormal nailfold capillaries

Digital ulcers

OutcomeRR (95% CI)
Stroke8.59 (1.02–72.00)
OutcomeSSc-sarcoidosisSSc
Sarcoidosis preceding SSc66.66%— not stated in the abstract
Sarcoidosis manifestations
Pulmonary66.66%— not stated in the abstract
Lymphadenopathy66.66%— not stated in the abstract
Arthritis50%— not stated in the abstract
Cutaneous33.33%— not stated in the abstract
Hepatic16.66%— not stated in the abstract
Female to male sex ratio5:14.5:1

— not stated in the abstract

Prevalence of SSc-sarcoidosis

SSc-sarcoidosis prevalence
0.30%

ILD

Tended to be more frequent with SSc-sarcoidosis; differences not significant

Pulmonary hypertension

Tended to be more frequent with SSc-sarcoidosis; differences not significant

Abnormal nailfold capillaries

Tended to be less frequent with SSc-sarcoidosis; differences not significant

Digital ulcers

Tended to be less frequent with SSc-sarcoidosis; differences not significant

Original publication

Epidemiology and Survival of Systemic Sclerosis–Sarcoidosis Overlap Syndrome. J Rheumatol. Published 1 February 2023. doi:10.3899/jrheum.220877

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.